NVST - NYSE
Envista Holdings Corp
$22.40
-0.47%Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
At a Glance
Live SnapshotEnvista Holdings Corp Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Acceptable margins but limited operational leverage. Operating expense control is important.
Net Profit Margin
Minimal profitability after all expenses. Limited financial flexibility for reinvestment or shareholder returns.
Effective Tax Rate
Higher tax burden may reflect limited tax optimization or operations in high-tax jurisdictions.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
Envista Holdings Corp Income Statement
NVST • NYSE
| Envista Holdings Corp Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||
2.7B | 2.5B | 2.6B | 2.6B | 2.5B | 1.9B | 2.3B | 2.8B | 2.8B | 2.8B | |
GROSS PROFIT | ||||||||||
(1.2B) | (1.1B) | (1.1B) | (1.1B) | (1B) | (856M) | (933.1M) | (1.2B) | (1.2B) | (1.2B) | |
1.5B | 1.4B | 1.5B | 1.5B | 1.5B | 1.1B | 1.4B | 1.6B | 1.6B | 1.6B | |
OPERATING INCOME | ||||||||||
(1.3B) | (2.4B) | (1.4B) | (1.2B) | (1.2B) | (1B) | (1.1B) | (1.3B) | (1.2B) | (1.2B) | |
(1.2B) | (1.1B) | (1B) | (1B) | (989.5M) | (858.8M) | (970.1M) | (1.1B) | (1B) | (1B) | |
(114M) | (99.1M) | (93.8M) | (100.1M) | (100.5M) | (86.7M) | (133.1M) | (172M) | (172.4M) | (142.8M) | |
225.7M | -1B | 31.5M | 319.2M | 306.2M | 43.5M | 235.7M | 298.4M | 386.6M | 402.8M | |
PRE-TAX INCOME | ||||||||||
(36.6M) | (46.4M) | (63.4M) | (38.4M) | (54.1M) | (62.5M) | (3.5M) | (0.0) | (0.0) | (0.0) | |
-36.6M | -46.4M | -63.4M | -38.4M | -54.1M | -62.5M | -3.5M | 0.0 | 0.0 | 0.0 | |
(0.0) | (1.2B) | (295.9M) | (40.7M) | (66.2M) | (84.1M) | (12.8M) | (26.4M) | (35.9M) | (33.3M) | |
-48.5M | -46.5M | -86.4M | -35.3M | -51.7M | -63.5M | -2M | 2.7M | 100K | -1.1M | |
177.2M | -1.1B | -54.9M | 283.9M | 254.5M | -20M | 233.7M | 301.1M | 386.7M | 401.7M | |
NET INCOME | ||||||||||
(130.2M) | (33.9M) | (45.3M) | (45.9M) | -9M | -62.5M | (49.6M) | (70.4M) | (85.6M) | (129.7M) | |
47M | -1.1B | -100.2M | 243.1M | 340.5M | 33.3M | 217.6M | 230.7M | 301.1M | 272M |
SEC Filings
NVST - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | June 03, 2026 | May 28, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 21, 2026 | May 19, 2026 | 2026 | |
10-Q 10-Q 2026 Q2 Q2 | May 06, 2026 | April 03, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 06, 2026 | May 06, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 07, 2026 | December 31, 2025 | 2025 | |
10-K 10-K 2025 FY FY | February 12, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 05, 2026 | February 05, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | October 30, 2025 | September 26, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 29, 2025 | October 29, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 29, 2025 | October 29, 2025 | 2025 |
Related Guides
Continue your NVST research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.